| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |